During the past decade, Leber- und Studienzentrum am Checkpoint conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leber- und Studienzentrum am Checkpoint" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Leber- und Studienzentrum am Checkpoint" are "Hepatitis B, Chronic" (2 trials), "Chronic Hepatitis B" (1 trials), "Chronic Hepatitis C" (1 trials), "Hepatitis C, Chronic" (1 trials) and "Primary Biliary Cirrhosis (PBC)" (1 trials). Many other conditions were trialed in "Leber- und Studienzentrum am Checkpoint" in a lesser frequency.

Most popular intervention types in "Leber- und Studienzentrum am Checkpoint" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Copegus®" (1 trials), "Experimental: Seladelpar / MBX-8025 200 mg" (1 trials), "Experimental: Seladelpar / MBX-8025 50 mg" (1 trials), "GS-9451" (1 trials) and "GS-9451 placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Leber- und Studienzentrum am Checkpoint" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Leber- und Studienzentrum am Checkpoint". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Leber- und Studienzentrum am Checkpoint, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Leber- und Studienzentrum am Checkpoint, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".